Treatment of diabetes mellitus after renal transplantation
This presentation will discuss complications associated with kidney transplant that include transient post-transplant hyperglycemia and post-transplant diabetes mellitus in order to provide the pharmacist tools to distinguish and diagnose between the two. Pharmacists will receive in-depth pathophysiology of the kidney and its role in glucose homeostasis. Additionally, pharmacists will be able to recognize and analyze common immunosuppressants used in kidney transplant that may induce hyperglycemia (e.g., glucocorticoids, calcineurin inhibitors, etc). By the end of this presentation, pharmacists will be able to recommend pharmacologic treatment options that are patient-specific for the kidney transplant population.
- Identify post-transplantation diabetes mellitus (PTDM)
- Analyze the role immunosuppressants play in contributing to PTDM
- Recommend pharmacologic treatment options for patients presenting with PTDM
Relevant financial relationships: Nadia Hellenga (planning committee member) received a speaker honorarium from Veloxis Pharmaceuticals
- 1.00 ACPE Pharmacist
- 1.00 General CEU – Attendance